Market revenue in 2022 | USD 283.7 million |
Market revenue in 2030 | USD 452.9 million |
Growth rate | 6% (CAGR from 2022 to 2030) |
Largest segment | Dietary supplements |
Fastest growing segment | Dietary Supplements |
Historical data | 2018 - 2021 |
Base year | 2022 |
Forecast period | 2023 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OTC pharma products, Dietary Supplements |
Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
Dietary supplements was the largest segment with a revenue share of 93.44% in 2022. Horizon Databook has segmented the Spain menopause market based on otc pharma products, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
Manufacturers are adopting strategies such as the launch of dietary supplements in different flavors to attract more customers. In June 2017, Bioiberica Human Health launched Articolágeno, a food supplement with vitamin C, magnesium, and hydrolyzed collagen. The product contains a patented ingredient, Mobilee, which has a high concentration of hyaluronic acid and is indicated for women at risk of joint pain, especially during menopause.
It was estimated that around 61% of women suffer from joint pain due to decreased estrogen levels during menopause. The high prevalence of health issues associated with menopause and the launch of products focused on meeting the growing health demands are expected to propel the market.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account